ASAM serves its members in many ways. One of the most important ways is by helping to play an active role in shaping government policies that affect their livelihoods and the lives of their patients.

ASAM advocates for policies that promote access to high-quality treatment and recovery support services for the 22 million Americans who suffer from a substance use disorder. The information here will help you stay up to date on emerging issues, enable you to take action and become an advocate for your patients and your practice, and learn about how ASAM is working with government, insurers and other national organizations to promote policies that advance addiction medicine.


Opioid misuse and overdose are a public health crisis in the United States.  ASAM and others have come together as the Coalition to Stop Opioid Overdose to advance meaningful legislative and regulatory policies this year in response to the opioid epidemic.

2016 NPF Training_472x176 

2018 NPF Training

Audio, text, slides, photos and selected 5-minute videos segments from the 2018 NPF/ ASAM Training held at the 49th ASAM Annual Conference in San Diego, CA.

Advocacy Toolkits_472x176

Advocacy Toolkits

Access resources that will equip you to advocate effectively for policies that promote addiction treatment and prevention.

Advocacy Events_472x176

Advocacy Issues

Find the latest information on issues of importance to the field of addiction medicine.

NPF training_472x176

Advocacy News

News and information about ASAM Advocacy.

Find a Policy Statement_472x176

Find a Policy Statement

Learn about ASAM's position on current policy issues.


Kelly Corredor
Director, Advocacy and Government Relations | 301.547.4111


Susan Awad
Policy Advisor | 301.547.4103


Corey Barton
Manager, Private Sector Relations | 301.547.4106


Brad Bachman
Manager, State Advocacy and Government Relations | 301.547.4107


Connor Galvin
Specialist, Federal Advocacy and Policy | 301.547.4135

Committee Chairs

Corey Waller, MD, MS, FACEP
Flora Sadri, DO, MPF, FAAFP

Chair and Vice Chair, Legislative Advocacy Committee


Jeffrey Selzer, MD, DFASAM
Randolph Holmes, MD, FASAM

Chair and Vice Chair, Public Policy Committee


Shawn Ryan, MD, MBA, FASAM
Frank James, MD, JD

Chair and Vice Chair, Payer Relations Committee

Advocacy Articles

ASAM Holds Alcohol Withdrawal Management Guideline Pre-Planning Meeting

by ASAM Staff | Dec 07, 2017

On October 16, 2017, ASAM and Institute for Research, Education, and Training in the Addictions (IRETA) staff, alongside clinical champions Dr. Richard Saitz, MD, MPH, FACP, DFASAM, and Dr. Darius Rastegar, MD, FASAM, and Quality Improvement Council representatives Dr. Margaret Jarvis, MD, DFASAM and Dr. Barbara Herbert, MD, DFASAM met at the IRETA offices in Pittsburgh, PA to begin planning the development of the alcohol withdrawal management guideline. 

The purpose of this meeting was to define the scope of ASAM’s newly launching guideline on alcohol withdrawal management. To clarify what to include, ASAM employed the PICOTS framework: population (the characteristics of the target population), intervention (treatments and other interventions used), comparison (intervention or control used for comparison), outcomes (outcomes of interested to be answered by evidence), timing (duration of time that is of interest), and setting (setting or context of interest). The PICOTS framework helps to identify key variables or clinical indicators involved in alcohol withdrawal management decisions, which will be used to draft clinical questions and search strategies during the literature review. Examples of some of the conclusions of this discussion are as follows: 

  • Population- No age parameters, pregnant and nursing women, adolescents 
  • Intervention- Benzodiazepines, antipsychotic/neuroleptic agents, nutrition/electrolytes/vitamins 
  • Comparison- Treatment-to-treatment, no treatment, late treatment initiation 
  • Outcomes- Mortality, delirium/confusion, seizures 
  • Timing- No particular timing considerations were discussed. 
  • Setting- Emergency/intensive care unit, general medical hospital, restricted settings (i.e. criminal justice) 

The group also discussed inappropriate practices and concerns, specific elements that would be included in the guideline, and ways to make the guideline useful for end users. Regarding the target audience, the final consensus was that the alcohol withdrawal management guideline will primarily be intended for clinicians who manage alcohol withdrawal in specialty and non-specialty settings, but it will also have utility for administrators, insurers, and legislators. 

The GRADE method will be used to extract data and evaluate the quality of the materials found in the literature review. The next meeting will take place on February 26, 2018 to develop a comprehensive list of potential guideline statements which will later be rated for appropriateness using the RAND/UCLA Appropriateness Method (RAM) by the expert panel. The list of statements will identify different combinations of clinical indicators in various clinical situations seen in alcohol withdrawal management. 

The alcohol withdrawal management guideline is anticipated to be finalized by the first quarter of 2019. For more information or questions, please contact